All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • sign in
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, March 30, 2023
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Petri dish and capsules
‘Wake-up call’

Current R&D investments insufficient to stem rising AMR tide

Jan. 28, 2020
By Peter Winter
No Comments
Adding further evidence about the global threat of the increase of antimicrobial-resistant (AMR) infections and dearth of new antibiotics to treat those conditions, Thomas Cueni, chair of the AMR Industry Alliance, said the findings from the alliance’s newly released report are “a wake-up call” as they estimate current investments in AMR-relevant R&D are not enough to sustain a viable pipeline that will be needed to combat infectious diseases globally.
Read More

Other news to note for Jan. 28, 2020

Jan. 28, 2020
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief, including: Adverum, Achillion, Alexion, Armata, Atrin, Avacta, Biolexis, Clover, Concert, Correvio, Horizon, Incyte, Innovia, Outlook, Oxford Gene, Predictive Technology, Satt Conectus, Seelos, Syndivia, Takeda
Read More
Coronavirus under electron microscope

Co-Diagnostics completes critical step in developing coronavirus diagnostic

Jan. 27, 2020
By Annette Boyle
No Comments
Salt Lake City-based Co-Diagnostics Inc. has finished the principle design work for a polymerase chain reaction (PCR) screening test for the novel coronavirus that has sickened nearly 3,000 with an acute respiratory illness and killed more than 80 people in Wuhan, China.
Read More

Week in review for Jan. 21-24, 2020: Gearing up for Wuhan coronavirus

Jan. 27, 2020
No Comments
A quick look back at top stories.
Read More

Other news to note for Jan. 27, 2020

Jan. 27, 2020
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief, including: Abbvie, Aeterna Zentaris, Akari, Allergan, Anika, Asahi Kasei, Aska, Aytu, Bavarian Nordic, Berlin-Chemie, Bionical, Biotheus, Bravovax, Emmaus, Eyepoint, Geovax, Genentech, Helsinn, Innovus, Lexicon, Nanthealth, Novo Nordisk, Ocumension, Oncoceutics, Oncolytics, Pharmamar, Pieris, Sorrento, Taiho, Tilt, Veloxis
Read More

Regulatory front for Jan. 23, 2020

Jan. 23, 2020
No Comments
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: Centers for Disease Control and Prevention, Centers for Medicare and Medicaid Services, Cowen Washington Research Group, European Commission, GE Healthcare
Read More

Other news to note for Jan. 23, 2020

Jan. 23, 2020
No Comments
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Avinger, Baylis Medical, Co-Diagnostics, Eptam Precision Solutions, Frazier Healthcare Partners, Fresenius Medical Care, Glaxosmithkline, HG Capital, Intelerad Medical Systems, Investissements Novacap, Myriad Genetics, New Heritage Capital, Oncimmune Holdings, Visquate
Read More

Wuhan coronavirus is emergency in China, not yet international concern: WHO

Jan. 23, 2020
By Nuala Moran
No Comments
LONDON – After a second day of deliberation, the World Health Organization (WHO) held off declaring that the novel coronavirus infection raging in Wuhan is an international health emergency, saying the low number of cases outside China means it is not time to escalate the response to this level.
Read More

Other news to note for Jan. 23, 2020

Jan. 23, 2020
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief, including: Altimmune, Basilea, Duckhorn, Enosi, Eversana, Evoke, Evotec, Hanx, Indivumed, Inovio, Moderna, Mundipharma, Onconova, Paion, Pfizer, Sanofi, Seelos, Summit, Synthorx
Read More
Coronavirus under electron microscope

WHO needs more information on novel coronavirus infection before declaring emergency

Jan. 22, 2020
By Nuala Moran
No Comments
LONDON – The World Health Organization held off declaring the novel coronavirus infection that has emerged in Wuhan, China, an international public health emergency, despite the fact that the number of confirmed cases tripled in the past week and the infection has spread to several other countries, including the U.S.
Read More
Previous 1 2 … 484 485 486 487 488 489 490 491 492 … 503 504 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 29, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for March 29, 2023.
  • Kirill Pevzner and Eran Seger - Protai

    AI drug discovery startup Protai raises $12M in seed funding

    BioWorld
    Artificial intelligence (AI)-powered drug discovery startup Protai Bio Ltd. raised $12 million in additional seed funding, bringing the total amount to $20...
  • Elderly woman holding illustration of brain with missing puzzle piece

    ‘Not a slowdown, a reversal’: Truebinding tackling Alzheimer’s via galectin-3

    BioWorld
    In Alzheimer’s, the amyloid beta hypothesis has proved most persistent in terms of drug development efforts to date, but aggregation of other pathogenic factors –...
  • Gold wireframe handshake

    A $4 million handshake with investor helps propel First Wave Biopharma’s CF offering

    BioWorld
    An investor has seen promise in First Wave Biopharma Inc.’s targeted, systemic gastrointestinal disease biotherapeutics, offering $4 million in a private...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing